Danofloxacin Mesylate

47 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

5740.0%

Death Rate

Active Ingredients

Danofloxacin Mesylate

Administration Routes

SubcutaneousUnknownTopicalIntramuscularIntravenousOther

Species Affected

Cattle 36

Unknown 8

Human 2

Dog 1

Most Affected Breeds

Cattle (other) 17

Mixed (Cattle) 15

Unknown 10

Aberdeen Angus 2

Cattle (unknown) 1

Crossbred Bovine/Cattle 1

Black Mouth Cur 1

Most Reported Reactions

Death 22

Lack of efficacy (bacteria) - NOS 13

Lack of efficacy - NOS 12

Unclassifiable adverse event 4

Necropsy performed 4

Uncoded sign 3

Malaise 3

Anaphylaxis 2

Accidental exposure 2

Incorrect route of drug administration 2

Lameness 2

Drug dose administration interval too long 2

Outcome Breakdown

Died

26 (40.6%)

Outcome Unknown

23 (35.9%)

Recovered/Normal

7 (10.9%)

Ongoing

4 (6.3%)

Recovered with Sequela

3 (4.7%)

Euthanized

1 (1.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.